z-logo
open-access-imgOpen Access
[Retracted] Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway
Author(s) -
Dan Jin,
Yan Wu,
Shao Cuijie,
Yong Gao,
Deqiang Wang,
Jiwei Guo
Publication year - 2020
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2020.7830
Subject(s) - epithelial–mesenchymal transition , audience measurement , cisplatin , cancer , blot , clinical oncology , cancer research , oncogene , biology , cell cycle , medicine , pathology , genetics , political science , chemotherapy , metastasis , law , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom